Flutamide (Eulexin®) is a medicine approved for the treatment of prostate cancer. Specifically, it is approved to treat Stage IIB to III (Stages B2 to C) and Stage IV (Stage D2). This medicine is always combined with another product: a gonadotropin-releasing hormone agonist. Together, the two drugs affect the production and action of testosterone, which inhibits the growth of cancer cells.
It is important to review the safety information for this product before beginning treatment with flutamide. For example, your healthcare provider needs to know about any allergies you may have and any other drugs or supplements you are taking.
(Click Flutamide for more information on this product, including possible side effects, dosing guidelines, and generic availability.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob. Accessed June 24, 2011.
Flutamide. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2011. Available from Wolters Kluwer Health, Inc. Accessed June 25, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click